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Abstract
Background—Uncontrolled asthma decreases quality of life and increases health care use. Most 
people with asthma need daily use of long-term control (LTC) medications for asthma symptoms 
and to prevent asthma attacks. Ongoing assessment of a person’s level of asthma control and 
medication use is important in determining the effectiveness of current treatment to decrease 
frequency and intensity of symptoms and functional limitations.
Objective—To assess the use of LTC medication among children and adults with current asthma 
and identify contributing factors for LTC medication use.
Methods—We used the 2006–2010 Behavioral Risk Factor Surveillance System (BRFSS) child 
and adult Asthma Call-back Survey (ACBS) data to assess level of asthma control and LTC 
medication use. Asthma control was classified as well-controlled and uncontrolled using 
guideline-based measures. We used multivariable logistic regression models to identify 
contributing factors for LTC medication use and having uncontrolled asthma.
Results—Among persons with current asthma, 46.0% of children and 41.5% of adults were 
taking LTC medications and 38.4% of children and 50.0% of adults had uncontrolled asthma.
Among children who had uncontrolled asthma (38.4%), 24.1% were taking LTC medications and 
14.3% were not taking LTC medications. Among adults who had uncontrolled asthma (50.0%), 
26.7% were taking LTC medications and 23.3% were not taking LTC medications.
Conclusions—Using BRFSS ACBS data to assess the level of asthma control and LTC 
medication use can identify subpopulations of persons with asthma who receive suboptimal 
treatment, for which better asthma-related medical treatment and management are needed.
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Asthma affects nearly 26 million people, including 7.0 million children [1]. For most people 
with asthma, daily use of medications for long-term control (LTC) of symptoms is the 
cornerstone of care in controlling asthma symptoms and preventing recurrent exacerbations 
of asthma [2]. The level of asthma control, described by the frequency and intensity of 
symptoms and functional limitations, is a function of underlying severity, responsiveness to 
treatment, and adequacy of asthma care and management. Treatment for asthma is generally 
tailored to severity and further adjusted based on the level of control [2]. In addition to 
socioeconomic and environmental factors [3–5], non-adherence to treatment, suboptimal 
treatment, or resistance to treatment [6–10] can affect the level of asthma control. A 
systematic literature review indicates that adherence to treatment was associated with fewer 
severe asthma exacerbations [9]. Uncontrolled asthma lead to decreased quality of life and 
increased health care use [11,12]. Therefore, the ongoing assessment of a person’s level of 
asthma control and medication use is essential in determining the effectiveness of current 
treatment in decreasing frequency and intensity of symptoms and functional limitations [2]. 
Although previous studies provided population-based estimates of asthma control levels and 
use of LTC medications among children and adults with asthma [13–15], limited 
information is available on population-based estimates of LTC medications use by level of 
asthma control among children and adults with uncontrolled asthma.
In this study, we aim to answer the following research questions: “Do all persons with 
uncontrolled asthma use LTC medications as recommended” and if not, “what are the 
contributing factors for LTC medication use.” We assessed the use of LTC medication and 
identify contributing factors for its use among children and adults with uncontrolled asthma 
in the states that participated in the Centers for Disease Control and Prevention (CDC) 
Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back Survey (ACBS). To 
provide information on the study population, those with uncontrolled asthma, we also 
assessed uncontrolled asthma status among adults and children with current asthma. We 
used impairment measures adapted from the National Asthma Education and Prevention 
Program (NAEPP) 2007 guidelines to determine the level of asthma control [2,13,14].
Methods
Survey Data description
Similar to our previous publication [13], we used 5 years of BRFSS child and adult ACBS 
data (2006–2010) to obtain stable estimates. We analyzed child and adult ACBS data 
separately because CDC’s BRFSS collects and maintains the data separately. Our study 
included children (aged 0–17 years) from 35 states and adults (aged 18 years and older) 
from 40 states and the District of Columbia.
The Air Pollution and Respiratory Health Branch (APRHB) of CDC’s National Center for 
Environmental Health (NCEH) developed and funds the BRFSS ACBS. The ACBS has been 
used as a follow-up survey to the BRFSS since 2006. Although BRFSS is a state-based, 
random-digit–dialed telephone survey of non-institutionalized U.S. adults, it contains a 
Random Child Selection module and a Child Asthma Prevalence module. Both modules 
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were used in participating states to identify households with a child who had asthma to 
administer the child ACBS. BRFSS respondents or proxy servers who report a child ever 
being diagnosed with asthma are eligible for the ACBS. Only one adult or one child per 
household can participate in the ACBS. An adult family member serves as a proxy 
respondent for the selected child.
The ACBS collects in-depth information about asthma symptoms and episodes or attacks, 
self-management education, health care use and access, medication use, comorbidities, and 
environmental allergens and irritants [16]. The ACBS response rate for children and adults 
varies by state and year. During 2006–2010, the median ACBS response rates ranged from 
47.6% to 53.7% for children (via adult proxies) and from 47.5% to 54.3% for adults. The 
data include sample weights to adjust for the unequal probability of selection, the 
disproportionate selection of population subgroups relative to the state’s population 
distribution, and disproportionate nonresponse [16]. In addition, the combined 2006–2010 
child and adult data files were proportionally re-weighted for each state to account for 
differences in sample size by year and the number of years each state participated. More 
information on participating states, weight calculation, and the response rate can be found in 
the ACBS Summary Data Quality Report for each year at http://www.cdc.gov/brfss/acbs 
[16].
Variables
Participants were asked, “Have you ever been told by a doctor, nurse, or other health 
professional that you (the child) had asthma?” and “Do you (the child) still have asthma?”
[1]. Respondents who answered “yes” to both questions were considered to have current 
asthma. This is consistent with the methodology used with previous CDC publications.
Level of asthma control was classified as well-controlled and uncontrolled asthma using 
three impairment measures: daytime symptoms, night-time symptoms, and use of short-
acting β2 agonists for symptom control (not for prevention of exercise-induced 
bronchospasm). Respondents were assigned to each category based on their most impaired 
level among the three impairment measures [2,13,14,17]. This is an adaptation of the 2007 
NAEPP guidelines because the ACBS did not include all required measures for current 
impairment (eg, pulmonary function measures) and for future risk assessment (eg, asthma 
exacerbations, progressive decline in lung function in adults, or reduced lung growth in 
children) [2,17]. We did not include one of the impairment measures, interference with 
normal activities, because the reference time for the question was the past 12 months and 
should only include more recent experiences [17]. We categorized persons with current 
asthma into four subgroups based on their level of asthma control and long-term controlled 
(LTC) medication use: well-controlled asthma and taking LTC medications; well-controlled 
asthma and not taking LTC medications; uncontrolled asthma and taking LTC medications; 
and uncontrolled asthma and not taking LTC medications. Qualifying LTC asthma 
medications included inhaled corticosteroids, systemic corticosteroids, long-acting β2 
agonist, leukotriene receptor antagonists, methylxanthines, and immunomodulators. For the 
analyses, we combined responses for all subgroups of LTC asthma medications because of 
small sample sizes for the subgroups.
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For children and adults, analysis variables included demographic characteristics (age, sex, 
race/ethnicity), annual household income, health care coverage, and routine medical care 
visits. For adults, body mass index (BMI) (defined as weight in kilograms divided by height 
in squared meter; obese = BMI ≥30) was considered in the analysis. The presence of chronic 
obstructive pulmonary disease (COPD), depression, and smoking status were also included 
in the analysis for adults. The COPD variable includes responses to the question asking, 
“Have you ever been told by a doctor or other professional that you have emphysema/
chronic bronchitis/COPD?”
Statistical analysis
We analyzed data using SAS-callable SUDAAN (version 11.0, RTI International, Research 
Triangle Park, NC) to account for the complex sampling design of the BRFSS ACBS. 
During the analyses, sample weights were used to produce estimates generalizable to a 
participating state’s population. We assessed LTC asthma medication use and identified 
contributing factors among children and adults with uncontrolled asthma. To provide 
information on the study population, we assessed uncontrolled asthma status among adults 
and children with current asthma similar to our previous publication [13]. We used the chi-
square test to test for group differences and multivariable logistic regression to test for 
associations between response variable (dependent variable) and independent variables. We 
also calculated weighted percent estimates, adjusted prevalence ratios (aPRs) (predicted 
marginal risk ratio), and 95% confidence intervals (CI). The aPR is considered statistically 
significant if 95% CI does not include the null value of 1. All aPRs for children and adults 
were adjusted for age, sex, race/ethnicity, annual household income, health care coverage, 
and routine care visits. In addition, prevalence ratios for adults were adjusted for smoking, 
BMI, COPD, and depression. Statistical significance was determined as a p <0.05 by a non-
directional z-test or by non-overlapping 95% CIs. Terms such as “higher than,” “less than,” 
“more likely,” and “less likely” indicate a statistically significant difference. Terms such as 
“similar” and “no difference” indicate differences that are not statistically significant. 
Relative standard error (RSE), defined as standard error divided by prevalence estimate, was 
used as a measure of an estimate’s reliability (an RSE <0.30 indicates a “reliable” estimate) 
[18].
Results
Children with current asthma
Characteristics—In the combined 2006–2010 BRFSS ACBS survey sample, 9697 
children had current asthma.
Most of the children with current asthma were male (57.0%) and non-Hispanic white 
(57.2%). By age, 18.3% of children with asthma were aged 0–4 years, 43.5% were aged 5–
11 years, and 38.2% were aged 12–17 years. Among children with asthma, 11.7% lived in 
homes with annual household incomes of less than $15 000. Of children with asthma, 96.4% 
had health care coverage, and 74.6% had routine medical care visits, 46.0% (24.1% of 
children with uncontrolled asthma and 21.9% of children with well-controlled asthma) were 
taking LTC asthma medications, and 38.4% had uncontrolled asthma.
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Among children with asthma who had uncontrolled asthma (38.4%), 24.1% were taking 
LTC medications and 14.3% were not taking LTC medications (Table 1). Among children 
with asthma who had well-controlled asthma (61.6%), 21.9% were taking LTC medications 
and 39.7% were not taking LTC medications (Table 2).
Factors associated with asthma control among children with current asthma
—Prevalence of uncontrolled asthma was higher among children aged 0–4 years with 
asthma (47.3%; aPR = 1.3 [1.1–1.5]) and among those with one or more routine medical 
care visits (44.7%; aPR = 2.2 [1.8–2.6]) than those aged 12–17 years (34.8%) and those 
without routine medical care visits (20.6%), respectively (Table 1).
Factors associated with LTC medication use among children with 
uncontrolled asthma—Among children with uncontrolled asthma, children aged <12 
years (0–4 years: aPR = 1.4 [1.2–1.6]; 5–11 years: aPR = 1.3 [1.2–1.5]) were more likely to 
use LTC medications than children aged 12–17 years. Also, children with routine care visits 
(aPR = 1.3 [1.1–1.6]) were more likely to use LTC medications than children who did not 
have routine care visits. Children with annual household income of <$15 000 were less 
likely (aPR = 0.7 [0.5–0.9]) to use LTC medications for asthma than children with 
household income of ≥$75 000. Sex, race/ethnicity, and health care coverage status were not 
associated with uncontrolled asthma and LTC medication use (Table 1).
Adults with current asthma
Characteristics—In the combined 2006–2010 BRFSS ACBS sample, 52210 adults had 
current asthma.
Most of the adults with current asthma were female (63.1%) and non-Hispanic whites 
(74.6%). Among adults with current asthma, 30.7% were aged 18–34 years, 18.5% were 
aged 35–44 years, 19.6% were aged 45–54 years, 15.9% were aged 55–64 years, and 15.3% 
were aged ≥65 years. Also, 14.7% had annual household incomes of <$15 000, 86.9% had 
health care coverage, 55.2% reported having one or more routine medical care visits, 19.5% 
were current smokers, 39.4% were obese, 34.6% had COPD, 34.7% had depression, 41.5% 
were taking LTC asthma medications (26.7% of adults with uncontrolled asthma and 14.8% 
of adults with well-controlled asthma), and 50.0% had uncontrolled asthma (Table 3). 
Among adults with asthma who had uncontrolled asthma (50.0%), 26.7% were taking LTC 
medications and 23.3% were not taking LTC medications (Table 3). Among adults with 
asthma who had well-controlled asthma (50.0%), 14.8% were taking LTC medications and 
35.2% were not taking LTC medications (Table 2).
Factors associated with asthma control among adults with current asthma—
The prevalence of uncontrolled asthma was similar among each of the sex, age, and race/
ethnicity groups; however, the prevalence decreased as annual household income increased. 
The prevalence estimates ranged from 66.2% among adults with annual household income 
of less than $50000 to 38.1% among adults with household income of ≥$75000. Prevalence 
of uncontrolled asthma was higher among adults without health care coverage (54.7%) and 
those having routine medical care visits (60.4%). Uncontrolled asthma was also higher 
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among adults who were current smokers (64.8%), had COPD (66.3%), or had depression 
(58.9%), compared with those without these conditions. Adjusting for covariates (age, sex, 
race/ethnicity, health care coverage, routine medical care visits, smoking status, BMI status, 
COPD, depression) did not alter these associations. There was a statistically significant 
association between asthma control status and obesity status prior to adjusting for the 
aforementioned covariates; however, this association did not remain significant after the 
adjustment. Uncontrolled asthma prevalence was 54.8% among obese adults and 46.6% 
among non-obese adults and aPR was 1.1 [1.0–1.1]) (Table 3).
Factors associated with LTC medication use among adults with uncontrolled 
asthma—Among adults with uncontrolled asthma, LTC medication use was significantly 
associated with being aged ≥35 years (35–44: 21.7%, aPR = 1.2 [1.1–1.3]; 45–54: 23.4%, 
aPR = 1.2 [1.1–1.4]; 55–64: 21.6%, aPR = 1.3 [1.2–1.4]; ≥65: 21.7%, aPR = 1.3 [1.2–1.4]), 
compared with the adults aged 18–34 years. Although prevalence of uncontrolled asthma did 
not differ by sex or race/ethnicity, Hispanics with uncontrolled asthma were less likely to 
take LTC medications than non-Hispanic whites (21.8% vs. 27.4%; aPR = 0.8 [0.7–0.9]) 
(Table 3). LTC medication use also was more prevalent among adults with heath care 
coverage (28.0%) and those having routine medical care visits (38.6%) than the 
corresponding reference groups (no heath care coverage [19.1%] and no routine medical 
care visits [11.6%]). Adjusting for covariates did not alter these associations. Adults with 
uncontrolled asthma who smoked were less likely to take LTC medications (26.5%) than 
those who never smoked (24.0%) (aPR = 0.8 [0.7–0.8]). In addition, the associations 
between LTC use and annual household income, being obese, having COPD, or having 
depression were statistically significant before the adjustment, but not after the adjustment 
(Table 3).
Discussion
We assessed the use of LTC medications for asthma control among children and adults with 
current asthma and identified factors associated with the medication use by analyzing 2006–
2010 BRFSS ACBS data from participating states. We identified four distinct subgroups of 
people with asthma based on their levels of asthma control and LTC medication use. Our 
findings show that not all children and adults who had uncontrolled asthma were taking LTC 
medications (14.3% and 23.3%, respectively) and not all who were taking LTC had their 
asthma controlled: 24.1% of children and 26.7% of adults with asthma were taking LTC 
medications but had uncontrolled asthma. Possible explanations for these findings are 
suboptimal treatment [6], non-adherence to treatment regimens for various reasons [8–10], 
resistance to treatment [7], or that providers are not following the NAEPP 2007 guidelines 
[2].
According to the NAEPP 2007 guidelines, all persons with uncontrolled asthma should be 
taking/prescribed LTC medications, and their treatment regimen should be adjusted 
periodically based on the level of asthma control [2]. Those with uncontrolled asthma who 
are not taking LTC medications need a treatment regimen that includes LTC medications. 
Those who are taking LTC but still have uncontrolled asthma should have their treatment 
regimen (type and dose of medications) adjusted [2]. Treating those with uncontrolled 
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asthma with LTC medications appropriately, as defined in the NAEPP 2007 guidelines, is an 
important component of asthma management.
The findings of this study are similar to the findings of previous publications [13–15] and 
state-specific reports [19], which indicate that socio-economic and demographic factors 
affect the prevalence of asthma control and medication use. For children and adults with 
asthma, age and routine care visits were strong predictors of asthma control and medication 
use. Among children with uncontrolled asthma, being aged 0–4 or 5–11 years, or having 
routine care visits were predictors of LTC use, and having <$15 000 annual household 
income was predictor of not using of LTC medication. Among adults with uncontrolled 
asthma, being aged ≥35 years, having routine care visits, or having health care coverage was 
significantly associated with medication use, whereas being a smoker or being a Hispanic 
was associated with not using medication. Having less than $50 000 annual household 
income or having comorbid conditions (obesity, COPD, or depression) were significantly 
associated with having uncontrolled asthma but were not associated with medication use.
Some of these associations are intuitive and expected based on previous publications [13–
15]. For example, persons having health coverage and routine medical care visits might have 
a greater chance of being diagnosed and treated. Although higher uncontrolled asthma 
prevalence among smokers might be explained by smoking which could impair the effect of 
inhaled corticosteroids, (the most commonly used LTC medications for controlling asthma) 
[20], we cannot explain our finding of smokers being less likely to be LTC medication users. 
This might warrant further investigation. In addition, despite controlling for income and 
health care coverage, being Hispanic was still significantly associated with not taking LTC 
medications. This might indicate the presence of other risk factors in this population and 
warrants further investigation. Identifying modifiable predictors (low income, not having 
health care coverage, smoking, or comorbid conditions) of uncontrolled asthma and 
medication use is an important step in developing targeted interventions and producing 
strategies that promote better asthma care and improve the health and well-being of persons 
with asthma and their families.
The strength of this study is the ability to assess the level of asthma control and LTC 
medication use among a large sample of children and adults with current asthma from states 
participating in the ACBS. The ACBS is the only survey that has data for guideline-based 
classification of asthma control [2] and identifies those taking LTC medications to evaluate 
population-based asthma control status and medication use.
This study has several limitations. First, the indicators for asthma control classification 
available in the ACBS circumscribed our findings. We were unable to include all of the 
specified elements from the NAEPP guidelines because of the nature of telephone surveys 
and the content of the ACBS questionnaire. Those missing elements included activity 
limitation, pulmonary function measures, asthma exacerbations that require oral 
corticosteroid, and lung growth status in children [2]. This limitation might alter asthma 
control prevalence estimates. However, it will not affect the assessment of LTC medication 
use because ACBS provides very detailed information on asthma medications, regardless of 
asthma control status. The definition of asthma control used here also is consistent with the 
Zahran et al. Page 7













definition in other reports of population-based estimates [13,14,19]. Another limitation is 
that the ACBS response rates for the participating states were around 50%. Low response 
rates might affect the results by introducing non-response bias, if survey respondents 
differed from non-responders on the characteristics studied. However, the BRFSS sampling 
and weighting procedures and varying response rates among states over the 5-year study 
period can minimize non-response effects on the results [16]. In addition, because of the 
cross-sectional nature of the survey data, we could not generally determine temporal 
sequence or causality. Finally, the findings cannot be generalized to people with current 
asthma in states that did not participate in the ACBS.
Conclusion
Despite national guidelines for managing asthma and available advanced medical treatments, 
not all children and adults with uncontrolled asthma were taking LTC medication and not all 
who were taking LTC medication had their asthma under control. Among children and 
adults with asthma who were taking LTC medications, 21.9% of children and 14.8% of 
adults had well-controlled asthma and about 20% of children and adults had uncontrolled 
asthma. Our findings indicate that multiple factors were significantly associated with either 
having uncontrolled asthma or taking LTC asthma medications. Those factors included age, 
routine care visits, low income, health care coverage, tobacco smoking, and co-morbid 
conditions including obesity, COPD, and depression. Development of targeted interventions 
or strategies aimed at reducing modifiable risk factors (low income, not having health care 
coverage, smoking, or comorbid conditions) can lead to better asthma control and improve 
the health and quality of life of people with asthma.
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